About CNRT
CNRT is a company based in Chengdu (China) founded in 2016 by Li Maoliang, Qian Jihui, and Cai Jiming.. CNRT has raised $274.14 million across 4 funding rounds from investors including China National Nuclear Corporation, STAR Capital and Neovision Capital. CNRT operates in a competitive market with competitors including BetaGlue Technologies, EMulate Therapeutics, RITA Medical Systems, Trod Medical and Medsphere, among others.
- Headquarter Chengdu, China
- Founders Li Maoliang, Qian Jihui, Cai Jiming
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$274.14 M (USD)
in 4 rounds
-
Latest Funding Round
$145 M (USD), Series E
Apr 07, 2026
-
Investors
China National Nuclear Corporation
& 18 more
-
Employee Count
Employee Count
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of CNRT
CNRT has successfully raised a total of $274.14M across 4 strategic funding rounds. The most recent funding activity was a Series E round of $145 million completed in April 2026. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 4
- Last Round Series E — $145.0M
-
First Round
First Round
(17 Jul 2019)
- Investors Count 19
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Apr, 2026 | Amount | Series E - CNRT | Valuation |
investors |
|
| Oct, 2025 | Amount | Series D - CNRT | Valuation | Shenzhen Capital Group , PICC Capital Investment Management | |
| Mar, 2024 | Amount | Series C - CNRT | Valuation | STAR Capital Partnership |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in CNRT
CNRT has secured backing from 19 investors, including venture fund and institutional investors. Prominent investors backing the company include China National Nuclear Corporation, STAR Capital and Neovision Capital. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
STAR Capital is focused on developing strategic asset businesses.
|
Founded Year | Domain | Location | |
|
-
|
Founded Year | Domain | Location | |
|
-
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by CNRT
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - CNRT
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Cnrt Comparisons
Competitors of CNRT
CNRT operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as BetaGlue Technologies, EMulate Therapeutics, RITA Medical Systems, Trod Medical and Medsphere, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
A radiotherapy platform for solid tumor treatment is developed.
|
|
| domain | founded_year | HQ Location |
Radiofrequency devices for cancer treatment are developed using ultra-low energy.
|
|
| domain | founded_year | HQ Location |
Oncology therapy products, including ablation and embolization systems, are developed.
|
|
| domain | founded_year | HQ Location |
Develops innovative RF-based focal ablation devices for tumor treatment.
|
|
| domain | founded_year | HQ Location |
Radiofrequency ablation devices for tumor treatments in organs are developed.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Frequently Asked Questions about CNRT
When was CNRT founded?
CNRT was founded in 2016 and raised its 1st funding round 3 years after it was founded.
Where is CNRT located?
CNRT is headquartered in Chengdu, China. It is registered at Chengdu, Sichuan, China.
Is CNRT a funded company?
CNRT is a funded company, having raised a total of $274.14M across 4 funding rounds to date.
What does CNRT do?
Chengdu Nuruit Medical Technology was founded in 2016 in Chengdu, China, and operates in the nuclear medicine sector. Medical isotopes are provided for the diagnosis and treatment of malignant tumors, along with radiopharmaceuticals technology. Nuclear medicine-related technical and scientific consulting services are offered. A pilot plant project for radiopharmaceuticals-based cancer treatment has been completed, and patents are held for items such as phosphorus-32 carbon microspheres and iodine-131 carbon microspheres.
Who are the top competitors of CNRT?
CNRT's top competitors include EMulate Therapeutics, BetaGlue Technologies and RITA Medical Systems.
Who are CNRT's investors?
CNRT has 19 investors. Key investors include China National Nuclear Corporation, STAR Capital, Neovision Capital, Chengdu Bio-Town Group, and Chengdu Industrial Investment Group.